MAGNESIUM OROTATE IN COMPLEX THERAPY OF METABOLIC DISORDERS IN PATIENTS WITH GOUT
In 25–90 % patients with gout we detect metabolic syndrome (MS), and on the contrary – in patients with MS significantly increases the risk of gout and hyperuricemia (HU). About 40–50 % of MS cases are combined with magnesium deficiency. Comprehensive treatment of MS with the addition of magnesium d...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Ukrainian |
| Published: |
Ukrmedknyha Publishing House
2017-04-01
|
| Series: | Vіsnik Naukovih Doslіdžen' |
| Subjects: | |
| Online Access: | https://ojs.tdmu.edu.ua/index.php/visnyk-nauk-dos/article/view/7353 |